115 related articles for article (PubMed ID: 3366768)
1. A synthetic analog of the calmodulin-binding domain of myosin light chain kinase inhibits melanotropin receptor function and activation of adenylate cyclase.
Gerst JE; Salomon Y
J Biol Chem; 1988 May; 263(15):7073-8. PubMed ID: 3366768
[TBL] [Abstract][Full Text] [Related]
2. Inhibition by melittin and fluphenazine of melanotropin receptor function and adenylate cyclase in M2R melanoma cell membranes.
Gerst JE; Salomon Y
Endocrinology; 1987 Nov; 121(5):1766-72. PubMed ID: 3665846
[TBL] [Abstract][Full Text] [Related]
3. Regulation of adenylate cyclase by beta-melanotropin in the M2R melanoma cell line.
Gerst JE; Sole J; Mather JP; Salomon Y
Mol Cell Endocrinol; 1986 Jul; 46(2):137-47. PubMed ID: 3013705
[TBL] [Abstract][Full Text] [Related]
4. Identification and characterization of melanotropin binding proteins from M2R melanoma cells by covalent photoaffinity labeling.
Gerst JE; Sole J; Hazum E; Salomon Y
Endocrinology; 1988 Oct; 123(4):1792-7. PubMed ID: 3416815
[TBL] [Abstract][Full Text] [Related]
5. Dual regulation of beta-melanotropin receptor function and adenylate cyclase by calcium and guanosine nucleotides in the M2R melanoma cell line.
Gerst JE; Sole J; Salomon Y
Mol Pharmacol; 1987 Jan; 31(1):81-8. PubMed ID: 3027527
[TBL] [Abstract][Full Text] [Related]
6. Calmodulin-binding peptides interfere with melanocyte-stimulating hormone receptor activity and stimulate adenosine 3',5'-monophosphate production in M2R mouse melanoma cells.
Eshel Y; Salomon Y
Endocrinology; 1994 Jan; 134(1):177-85. PubMed ID: 8275931
[TBL] [Abstract][Full Text] [Related]
7. Protein kinase C stimulates adenylate cyclase activity in prolactin-secreting rat adenoma (GH4C1) pituicytes by inactivating the inhibitory GTP-binding protein Gi.
Gordeladze JO; Björo T; Torjesen PA; Ostberg BC; Haug E; Gautvik KM
Eur J Biochem; 1989 Aug; 183(2):397-406. PubMed ID: 2569396
[TBL] [Abstract][Full Text] [Related]
8. Hormone-sensitive adenylate cyclase of prolactin-producing rat pituitary adenoma (GH4C1) cells: molecular organization.
Gordeladze JO; Sletholt K; Thorn NA; Gautvik KM
Eur J Biochem; 1988 Nov; 177(3):665-72. PubMed ID: 2904368
[TBL] [Abstract][Full Text] [Related]
9. Involvement of calmodulin in the regulation of adenylate cyclase activity in guinea-pig enterocytes.
Pinkus LM; Sulimovici S; Susser FI; Roginsky MS
Biochim Biophys Acta; 1983 Jul; 762(4):552-9. PubMed ID: 6191780
[TBL] [Abstract][Full Text] [Related]
10. PHrmonal specificity of the melanotropin-sensitive adenylate cyclase of mouse melanoma and effect of cyclic AMP on the tyrosinase activity of mouse melanoma cells, in vitro.
Lee TH; Lee MS
Biochim Biophys Acta; 1976 Aug; 444(1):181-91. PubMed ID: 8131
[TBL] [Abstract][Full Text] [Related]
11. Synthetic peptides based on the calmodulin-binding domain of myosin light chain kinase inhibit activation of other calmodulin-dependent enzymes.
Blumenthal DK; Charbonneau H; Edelman AM; Hinds TR; Rosenberg GB; Storm DR; Vincenzi FF; Beavo JA; Krebs EG
Biochem Biophys Res Commun; 1988 Oct; 156(2):860-5. PubMed ID: 2903735
[TBL] [Abstract][Full Text] [Related]
12. Rabbit skeletal muscle myosin light chain kinase. The calmodulin binding domain as a potential active site-directed inhibitory domain.
Kennelly PJ; Edelman AM; Blumenthal DK; Krebs EG
J Biol Chem; 1987 Sep; 262(25):11958-63. PubMed ID: 3624242
[TBL] [Abstract][Full Text] [Related]
13. Synthetic peptides corresponding to the calmodulin-binding domains of skeletal muscle myosin light chain kinase and human erythrocyte Ca2+ pump interact with and permeabilize liposomes and cell membranes.
Eshel Y; Shai Y; Vorherr T; Carafoli E; Salomon Y
Biochemistry; 1993 Jul; 32(26):6721-8. PubMed ID: 8392369
[TBL] [Abstract][Full Text] [Related]
14. Human pancreatic tumor growth hormone-releasing factor stimulates anterior pituitary adenylate cyclase activity, adenosine 3',5'-monophosphate accumulation, and growth hormone release in a calmodulin-dependent manner.
Schettini G; Cronin MJ; Hewlett EL; Thorner MO; MacLeod RM
Endocrinology; 1984 Oct; 115(4):1308-14. PubMed ID: 6148231
[TBL] [Abstract][Full Text] [Related]
15. Melanotropic peptide-conjugated beads for microscopic visualization and characterization of melanoma melanotropin receptors.
Sharma SD; Jiang J; Hadley ME; Bentley DL; Hruby VJ
Proc Natl Acad Sci U S A; 1996 Nov; 93(24):13715-20. PubMed ID: 8943000
[TBL] [Abstract][Full Text] [Related]
16. The calmodulin binding domain of chicken smooth muscle myosin light chain kinase contains a pseudosubstrate sequence.
Kemp BE; Pearson RB; Guerriero V; Bagchi IC; Means AR
J Biol Chem; 1987 Feb; 262(6):2542-8. PubMed ID: 3818608
[TBL] [Abstract][Full Text] [Related]
17. Evidence for receptor-regulated phosphotransfer reactions involved in activation of the adenylate cyclase inhibitory G protein in human platelet membranes.
Jakobs KH; Wieland T
Eur J Biochem; 1989 Jul; 183(1):115-21. PubMed ID: 2502397
[TBL] [Abstract][Full Text] [Related]
18. The interaction of calmodulin with the C-terminal M5 peptide of myosin light chain kinase.
Garone L; Steiner RF
Arch Biochem Biophys; 1990 Jan; 276(1):12-8. PubMed ID: 2297218
[TBL] [Abstract][Full Text] [Related]
19. Properties of a monoclonal antibody directed to the calmodulin-binding domain of rabbit skeletal muscle myosin light chain kinase.
Nunnally MH; Blumenthal DK; Krebs EG; Stull JT
Biochemistry; 1987 Sep; 26(18):5885-90. PubMed ID: 2445376
[TBL] [Abstract][Full Text] [Related]
20. A dose-response study of forskolin, stimulatory hormone, and guanosine triphosphate analog on adenylate cyclase from several sources.
Ruiz J; Shi QH; Ho RJ
Arch Biochem Biophys; 1986 Nov; 251(1):139-47. PubMed ID: 3024568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
